- Exclusive: Genentech closes infectious disease unit in wave of research layoffsRoche's Genentech underwent another round of layoffs this week in its early research and development group, Endpoints News has learned, which included shuttering two research units and the departur…Endpoints · 1mo ago↗ source
- Rare disease biotech Beren adds $300M from new financingsAnxiously awaiting an FDA decision this fall, Beren Therapeutics has added $300 million in new capital to help launch its rare disease drug. The biotech announced Wednesday that it raised $135 ...Endpoints · 1mo ago↗ source
- Parabilis CEO Mathai Mammen on biotech's record IPOParabilis Medicines cemented the largest biotech IPO in industry history on Wednesday with its $670 million debut on the Nasdaq. But the Cambridge, MA-based drug developer won't be celebrating at…